Executive leadership at Modular Medical.
Board of directors at Modular Medical.
Research analysts covering Modular Medical.
Recent press releases and 8-K filings for MODD.
Modular Medical, Inc. Shareholders Approve Increase in Authorized Shares and Reverse Stock Split
MODD
Proxy Vote Outcomes
- On January 23, 2026, Modular Medical, Inc. shareholders approved an increase in authorized common stock from 100,000,000 to 250,000,000 shares.
- Shareholders also approved an amendment to effect a reverse stock split at a ratio to be determined by the board of directors within one year of the Annual Meeting.
- An increase of 3,000,000 shares reserved for issuance under the 2017 Equity Incentive Plan was also approved by shareholders.
Jan 23, 2026, 10:00 PM
Modular Medical Receives Nasdaq Minimum Bid Price Rule Extension
MODD
Delisting/Listing Issues
- Modular Medical, Inc. (MODD) received a 180-day extension from Nasdaq to regain compliance with its minimum bid price requirement.
- The company now has until June 29, 2026, to meet the requirement.
- To regain compliance, the bid price of the common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days.
- This extension notice has no immediate effect on the listing or trading of the company's common stock on the Nasdaq Capital Market.
Dec 31, 2025, 1:47 PM
Modular Medical Announces Pricing and Closing of Public Offering
MODD
- Modular Medical, Inc. announced and priced a public offering of 12,173,000 shares of its common stock and accompanying warrants to purchase 6,086,500 shares of common stock.
- The offering was priced at a combined $0.77 for two shares of common stock and one warrant, yielding an effective price of $0.38 per share and $0.01 per warrant.
- The warrants are exercisable immediately upon issuance at $0.45 per share and will expire five years following the date of issuance.
- The gross proceeds to the company from the offering are expected to be approximately $4.68 million, before deducting underwriting discounts and expenses.
- The offering closed on December 11, 2025, with Newbridge Securities Corporation acting as the sole bookrunner.
Dec 11, 2025, 10:00 PM
Modular Medical Launches Public Offering and Prepares for Product Launch
MODD
Product Launch
Management Change
New Projects/Investments
- Modular Medical has launched an underwritten public offering of common stock along with warrants, managed by Newbridge Securities Corporation.
- The company is currently in the development stage with no current revenue but maintains a stable balance sheet, including a low debt-to-equity ratio of 0.07 and a current/quick ratio of 1.47.
- Modular Medical plans a commercial launch of its Pivot tubeless insulin patch pump in early 2026, following FDA clearance for its patch pump and a submitted 510(k) premarket application.
- David Bosshard has been appointed Head of International Operations to support the company's global expansion efforts.
Dec 9, 2025, 11:39 PM
Modular Medical, Inc. Announces Inducement Offer for Warrant Exercises
MODD
- Modular Medical, Inc. (MODD) entered into inducement offer agreements on September 22, 2025, to encourage the exercise of existing warrants.
- Holders of 1,519,200 2023 Warrants and 3,975,428 2025 Warrants agreed to exercise them at a reduced price of $0.68 per share.
- The company expects to receive approximately $3.7 million in gross proceeds from these exercises.
- In consideration, MODD will issue new warrants to purchase approximately 2,747,314 shares at an exercise price of $0.84 per share, with a term of exercise of 5 years from the date of issuance.
- The transaction is expected to close on or about September 25, 2025.
Sep 23, 2025, 12:30 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more